0 results found
We aim to create added value for your future
The main investment strategy of the fund is to provide its unitholders the opportunity to invest in local/foreign health and biotechnology sector. Minimum 40% of the total fund value will always be invested in local/foreign equity shares, debt instruments, depository receipts (ADR/GDR), lease certificates issued by companies operating in medical sector and/or companies providing services and products to these companies, as well as mutual funds and exchange traded funds that enable investment in the mentioned theme, while another minimum 40% will always be invested in local/foreign equity shares, debt instruments, depository receipts (ADR/GDR), lease certificates issued by companies operating in biotechnology sector and/or companies providing services and products to these companies, as well as mutual funds and exchange traded funds that enable investment in the mentioned theme. Asset allocation of the fund portfolio and the related currencies of these assets (TRY or FX) may vary according to the views of the portfolio manager depending on the market conditions.
Benchmark
* As of
*Represents year to date returns. For funds established after the beginning of the year, the returns are since inception.
**Past term Fund returns are not an indication of future returns.
The recorded fund price changes since the IPO date are listed. You can view price changes on different dates by selecting a date range or period.
